Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue
Total revenue	$ 616,933	$ 1,020,177
Operating expenses
Research and development	1,217,556	1,776,382
General and administrative	1,701,448	1,747,585
Sales and marketing	282,277	372,233
Transaction costs	245,322
Impairment of right-of-use asset		520,759
Impairment of intangibles assets	750,596
Total operating expenses	4,611,419	4,782,143
Operating loss	(3,994,486)	(3,761,966)
Other income (expense)
Interest and other income (expense)	87,335	(24,422)
Interest expense	(38,267)	(56,444)
Foreign currency transaction losses	(3,876)	(10,351)
Change in fair value of derivative financial instruments		67
Total other income (expense)	45,192	(91,150)
Loss before income taxes	(3,949,294)	(3,853,116)
Provision for income taxes
Net loss	(3,949,294)	(3,853,116)
Net loss available to common stockholders	$ (3,949,294)	$ (3,853,116)
Net loss per common share - basic and diluted	$ (0.53)	$ (8.25)
Weighted average shares outstanding - basic and diluted	7,393,232	467,286
Net loss	$ (3,949,294)	$ (3,853,116)
Other comprehensive income - foreign currency translations	39,477	2,826
Comprehensive loss	(3,909,817)	(3,850,290)
Product sales [Member]
Revenue
Total revenue	366,933	520,177
Operating expenses
Cost of products and services	276,554	220,702
Collaborations Revenue [Member]
Revenue
Total revenue	250,000	500,000
Service [Member]
Operating expenses
Cost of products and services	$ 137,666	$ 144,482